Monthly Cost Planning For Both Treatment Options
Mounjaro And Wegovy Doses: Understanding Monthly Cost Differences
When comparing Mounjaro and Wegovy doses, the monthly cost structure differs significantly between these two prescription-only medicines. Wegovy follows a 16-week dose escalation from 0.25mg to 2.4mg maintenance, while Mounjaro escalates over 20 weeks from 2.5mg to 15mg maintenance. The monthly financial commitment varies as doses increase, making it essential to understand the complete cost journey before starting either treatment.
EverydayMeds provides transparent pricing for both Mounjaro and Wegovy doses, allowing you to budget effectively throughout your weight management journey. Our GPhC-registered pharmacy (#9012878) ensures you receive genuine medicines with proper cold-chain storage and next-day delivery. Both treatments require clinical assessment and ongoing prescriber oversight, with costs clearly outlined at each dose level to avoid unexpected expenses.
Wegovy Dose Escalation Pricing: Month-By-Month Breakdown
Understanding Wegovy's monthly costs requires following the mandatory dose escalation schedule over 16 weeks. Weeks 1-4 start at £79.99 for 0.25mg (using code FIRST40 for new customers), progressing to £94.99 for 0.5mg in weeks 5-8, then £99.99 for 1mg in weeks 9-12. The penultimate dose of 1.7mg costs £139.99 for weeks 13-16, before reaching the maintenance dose of 2.4mg at £209.99 monthly from week 17 onwards.
For ongoing monthly budgeting, most patients will spend £209.99 per month once established on Wegovy's 2.4mg maintenance dose. Our bundle options like the Ultimate Stability Trio provide three months of maintenance supply for £649.99, reducing ordering frequency whilst ensuring treatment continuity. Returning customers benefit from code DOSE25 at checkout, with all pricing including clinical assessment, prescriber review, and next-day cold-chain delivery.
Clinical Evidence For Mounjaro And Wegovy Doses Effectiveness
Clinical trials demonstrate that both Mounjaro and Wegovy doses, when used alongside a reduced-calorie diet and increased physical activity, may support significant weight management outcomes. The STEP trial programme for Wegovy showed patients may achieve average weight loss of approximately 15% at 68 weeks, whilst SURMOUNT trials for Mounjaro indicated potential weight loss of up to 22.5% with the highest doses (Wilding et al., NEJM, 2021).
These prescription-only medicines work through different mechanisms - Wegovy targets GLP-1 receptors only, whilst Mounjaro targets both GIP and GLP-1 receptors as a dual agonist. Both require proper dose escalation to minimise side effects and optimise effectiveness, making the monthly cost investment worthwhile for many patients seeking sustainable weight management support.
How Different Mounjaro And Wegovy Doses Work In Your Body
Wegovy (semaglutide) functions as a GLP-1 receptor agonist, mimicking your body's natural incretin hormones that signal fullness after meals. This mechanism may help reduce appetite, promote satiety with smaller portions, and potentially decrease food cravings by acting on brain appetite centres. The graduated dosing schedule allows your body to adapt gradually, starting with lower concentrations and building tolerance over the 16-week escalation period. Each weekly injection maintains steady medication levels, supporting consistent appetite regulation throughout your treatment journey. The 2.4mg maintenance dose represents the optimal balance between effectiveness and tolerability for most patients in clinical trials.
Streamlined Ordering Process For Both Treatment Options
Accessing either Mounjaro or Wegovy doses through EverydayMeds begins with our 3-minute online clinical assessment, covering your medical history, current medications, and weight management goals. Our qualified prescribers review your assessment within 3 working days (or 24 hours with express service), ensuring clinical appropriateness before approving your prescription. Once approved, your chosen treatment ships via next-day delivery using specialised cold-chain transport to maintain temperature integrity from our GPhC-registered pharmacy. All pens arrive in temperature-controlled packaging with clear storage instructions and injection guidance. Our clinical team remains available throughout your treatment for ongoing support and dose adjustment consultations.
Storage Requirements And Practical Considerations
Both Mounjaro and Wegovy doses require refrigerated storage at 2-8°C before first use, though Wegovy offers superior travel flexibility with 6 weeks room temperature stability versus Mounjaro's 21 days. Each treatment uses pre-filled injection pens - Wegovy employs Novo Nordisk's FlexTouch technology whilst Mounjaro uses Eli Lilly's KwikPen system, both designed for easy self-administration. The dose escalation schedules cannot be skipped or accelerated, requiring consistent weekly injections at prescribed doses to maintain effectiveness and safety. Proper rotation of injection sites (thigh, abdomen, upper arm) helps prevent lipodystrophy and ensures consistent absorption. Always inspect pens before use, discarding any that appear cloudy, frozen, or contain particles.
Long-Term Financial Planning For Mounjaro And Wegovy Doses
Annual cost considerations for these treatments require understanding both the escalation phase and maintenance expenses. Wegovy patients typically invest approximately £1,260 during the first 16 weeks, followed by £2,520 annually at the 2.4mg maintenance dose. Mounjaro's longer escalation period and higher maintenance doses generally result in greater annual costs, though individual response may vary significantly between treatments.
EverydayMeds' bundle options help manage cash flow whilst ensuring treatment continuity - our Consistency bundles provide two months of the same dose, whilst Step-Up bundles cover multiple escalation phases in single orders. This approach reduces ordering frequency, minimises delivery costs, and prevents treatment interruptions that could compromise your weight management progress.
Making The Right Choice Between Treatment Options
Selecting between Mounjaro and Wegovy doses involves considering multiple factors beyond monthly costs, including individual response patterns, side effect profiles, and long-term sustainability. Both are available from EverydayMeds, and your prescriber can help determine which treatment aligns best with your medical history and weight management goals. Our clinical team provides ongoing support throughout your chosen treatment, monitoring progress and adjusting doses as clinically appropriate. Remember that successful weight management requires commitment to lifestyle changes alongside medication, making the monthly investment part of a comprehensive health improvement strategy. Contact our pharmacy team to discuss which option might suit your needs and budget most effectively.
Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026
